Standardization and Metrological Advancements in Cellular and Genomic Diagnostics for Cancer
A special issue of Cells (ISSN 2073-4409).
Deadline for manuscript submissions: 31 December 2025 | Viewed by 1219
Special Issue Editors
Interests: cancer genomics; assay standardization; precision medicine; molecular profiling; therapeutic targets
Special Issue Information
Dear Colleagues,
Precision medicine in oncology is rapidly advancing with genomics and cellular analyses, driven by technologies such as next generation sequencing (NGS) and high-resolution cellular assays. These advancements enable earlier and more precise diagnoses and improve targeted therapies. However, substantial variability in testing quality and comparability remains a significant barrier, affecting patient outcomes and the implementation of innovative diagnostic methods. This Special Issue addresses the development of standardized tools and approaches to ensure the quality and consistency of both genomic profiling and cellular analyses in cancer diagnostics. Topics include the establishment of reference measurement systems (RMSs), SI-traceable reference materials, and protocols to assess measurement uncertainty. Submissions on metrological approaches, reference methods and materials, and standardization strategies for both cellular and genomic cancer diagnostics are highly encouraged.
Dr. Jessica Petiti
Dr. Marika Fava
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cells is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- cancer diagnostics
- cellular analysis
- genomic profiling
- precision medicine
- metrology in diagnostics
- next generation sequencing (NGS)
- reference measurement systems (RMSs)
- quality assurance (QA)
- IVDR compliance
- SI-traceable standards
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
